Evaluating and Comparing Treatment Outcomes in Specialty Care

Speakers: Rich Gliklich, MD, CEO, OM1, Inc; and
Tom Renshaw, RPh, Senior Director of Business
Solutions, Acentrus Specialty

Is it possible to measure specialty care treatment outcomes at scale? How do outcomes compare for hospitals with payer and pharmacy access compared with outcomes in a hospital that has to work with an outside payer and pharmacy? During this session, speakers examine a pilot study that seeks to answer these questions, utilizing 2-plus years of electronic health records data from patients with rheumatoid arthritis and multiple sclerosis. Attendees will learn about the outcomes measures used, and how they were defined, and hear the results from this multi-hospital pilot. The speakers will also discuss why rheumatoid arthritis and multiple sclerosis were chosen for this study and why disease states may matter. Finally, they will address what these results mean for manufacturers and plan sponsors, and the future implications and opportunities that arise from this research.

Dr Gliklich is CEO of OM1, Inc, an outcomes and technology company focused on using deep clinical data and advanced analytics to measure and predict health outcomes for real-world evidence and value-based care. He is also leading a federally funded effort to standardize health outcomes measurement across and within conditions, called the Outcomes Measures Framework. Prior to OM1, Dr Gliklich was founder and CEO of Outcome (acquired in 2011) and an investor in healthcare IT with General Catalyst Partners. Dr Gliklich is a graduate of Yale University and Harvard Medical School, and he is a surgeon and professor at Harvard Medical School.

Mr Renshaw currently functions as the Senior Director of Business Solutions for Acentrus Specialty with responsibility for innovative business strategies and development. He has served as a subject matter expert in the areas of contracting, transitional care, population health management, informatics, 340B, and clinical software development.